SoftMedx Healthcare Limited (Stock Code: 00648) has convened an extraordinary general meeting (EGM) for 11:00 a.m. on 30 March 2026. The meeting will be conducted exclusively via live online webcast, with no physical attendance arrangement.

The sole ordinary resolution seeks shareholder approval for a specific mandate authorising the board to allot and issue up to 16.30 million new shares (“Scheme Shares”) at an issue price of HK$0.01 per share. The shares will be allotted under a scheme of arrangement between the company and its creditors pursuant to Sections 670 and 673 of the Hong Kong Companies Ordinance. The mandate is additional to any existing general or specific mandates previously granted.

Implementation of the share issue remains conditional on the Listing Committee of The Stock Exchange of Hong Kong Limited granting listing approval and permission to deal in the Scheme Shares.

Shareholders wishing to participate in the webcast must register via email at least two days before the EGM. Voting will be conducted through proxies, with completed forms to be lodged with Tricor Investor Services Limited no later than 48 hours before the meeting. Non-registered shareholders should coordinate with their custodians or nominees.

For voting entitlement, the register of members will be closed from 25 March 2026 to 30 March 2026 (both dates inclusive). Transfers intended to qualify must be lodged with Tricor Investor Services Limited by 4:30 p.m. on 24 March 2026.

The board currently comprises one executive director, Mr. Lin Pinzhuo, and three independent non-executive directors: Mr. Ngok Ho Wai, Ms. Tang Cuihuen and Mr. Yiu Chun Wing.